PAVmed CEO granted 350,000 restricted shares
Aklog Lishan reported acquisition or exercise transactions in this Form 4 filing.
Rhea-AI Filing Summary
Aklog Lishan reported acquisition or exercise transactions in this Form 4 filing.
PAVmed Inc. Chairman and CEO Lishan Aklog received a grant of 350,000 shares of restricted common stock, awarded at $0.00 per share as equity compensation. The restricted stock was granted under PAVmed's Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan and has a single vesting date of May 20, 2029. The award is subject to forfeiture if the required service period is not completed, tying the grant to long-term leadership retention. Following this grant, Dr. Aklog directly holds 357,614 shares of common stock, with additional indirect interests reported through family members and investment entities.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 350,000 shares
Grant/Award
5 txns
Insider
Aklog Lishan
Role
Chairman and CEO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 350,000 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 357,614 shares (Direct);
Common Stock — 5 shares (Indirect, By daughter);
Common Stock — 5 shares (Indirect, By son);
Common Stock — 9,904 shares (Indirect, By Pavilion Venture Partners LLC);
Common Stock — 45 shares (Indirect, By HCFP/AG LLC)
Footnotes (3)
- F1. Represents restricted stock granted to the reporting person under the Issuer's Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan with a single vesting date of May 20, 2029. Such restricted stock is subject to forfeiture if the requisite service period is not completed.
- F2. Dr. Aklog is a member and sole manager of Pavilion Venture Partners LLC, and therefore has sole voting and dispositive power over the securities held by this entity. Dr. Aklog disclaims beneficial ownership of securities held by this entity, except to the extent of his proportionate pecuniary interest therein.
- F3. Dr. Aklog is a co-manager of HCFP/AG LLC, and therefore has joint voting and dispositive power over the securities held by this entity. Dr. Aklog disclaims beneficial ownership of securities held by this entity, except to the extent of his proportionate pecuniary interest therein.
Key Figures
Restricted stock grant: 350,000 shares
Grant price: $0.00 per share
Vesting date: May 20, 2029
+5 more
8 metrics
Restricted stock grant
350,000 shares
Common stock awarded to CEO on 2026-04-02
Grant price
$0.00 per share
Price for restricted stock grant to CEO
Vesting date
May 20, 2029
Single vesting date for restricted stock award
Direct holdings after grant
357,614 shares
CEO direct PAVmed common stock following transaction
Indirect holdings via Pavilion Venture Partners LLC
9,904 shares
PAVmed common stock held by Pavilion Venture Partners LLC
Indirect holdings via HCFP/AG LLC
45 shares
PAVmed common stock held by HCFP/AG LLC
Indirect holdings by daughter
5 shares
PAVmed common stock reported as held by daughter
Indirect holdings by son
5 shares
PAVmed common stock reported as held by son
Key Terms
restricted stock, Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan, vesting date, dispositive power, +1 more
5 terms
restricted stock financial
"Represents restricted stock granted to the reporting person under the Issuer's Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan"
Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.
Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan financial
"granted to the reporting person under the Issuer's Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan"
vesting date financial
"with a single vesting date of May 20, 2029"
dispositive power financial
"therefore has sole voting and dispositive power over the securities held by this entity"
Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.
beneficial ownership financial
"disclaims beneficial ownership of securities held by this entity, except to the extent of his proportionate pecuniary interest therein"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did PAVmed (PAVM) report for CEO Lishan Aklog?
PAVmed reported that CEO Lishan Aklog received a grant of 350,000 shares of restricted common stock. The shares were awarded at $0.00 per share as equity compensation, increasing his direct holdings and aligning his interests with long-term company performance.
What conditions apply to Lishan Aklog’s new PAVmed (PAVM) restricted stock?
The restricted stock is subject to forfeiture if the required service period is not completed. All 350,000 shares vest on May 20, 2029, meaning continued service through that date is needed to fully secure the equity award.
What indirect PAVmed (PAVM) holdings linked to Lishan Aklog are disclosed?
The filing shows 5 PAVmed shares held by his daughter, 5 by his son, 9,904 by Pavilion Venture Partners LLC, and 45 by HCFP/AG LLC. Footnotes note his voting or dispositive power and disclaim beneficial ownership except for his pecuniary interest.
AI-generated analysis. How Rhea-AI works. Not financial advice.
